Baker Tilly Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Baker Tilly Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,630	Closed	-$222K	–	521
2021 Q4	$222K	Sell	3,630 -3,050	-46%	-$211K	0.02%	488
2021 Q3	$499K	Sell	6,680 -150	-2%	-$12.6K	0.07%	314
2021 Q2	$632K	Buy	6,830 +300	+5%	+$25.5K	0.1%	222
2021 Q1	$579K	Buy	6,530 +3,670	+128%	+$364K	0.12%	210
2020 Q4	$267K	Buy	+2,860	New	+$228K	0.08%	263

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Baker Tilly Wealth Management's ARKG Position: Q1 2022 in Review

Baker Tilly Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 3,630 shares — an estimated $222K sold.

Baker Tilly Wealth Management first reported a position in ARKG in Q4 2020 and held it in 5 quarters. The position peaked at $632K in Q2 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Baker Tilly Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Baker Tilly Wealth Management sold 3,630 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $222K.
Baker Tilly Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 5 quarters.
Baker Tilly Wealth Management's ARK Genomic Revolution ETF position peaked at $632K in Q2 2021.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Baker Tilly Wealth Management's 13F filing for Q1 2022, filed 27 Apr 2022.